Health Condition 1: null- Gram negative multidrug resistant bacterial infections
Conditions
Interventions
Intervention1: Colistimethate sodium Inj.: â?¢The dosage (Strengths available 1 & 2 million IU) of colistimethate sodium, given as IV injection, will be as per the prescribing information or discretio
Sponsors
Cipla Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Greater than 18 years 2.A written informed consent 3.Patients suitable for treatment with colistimethate sodium, including immuno-compromised patients
Exclusion criteria
Exclusion criteria: 1.Patients with hypersensitivity to colistimethate sodium or any exipients of its formulation. 2.Patients with Myasthenia gravis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical Parameters:Clinical and bacteriological response to the treatment.Timepoint: Throughout the study period | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinically significant changes in the vital signs, systemic examinations, ECG, chest radiograph and laboratory valuesTimepoint: Throughout the study period;Incidence and nature of adverse events Timepoint: Throughout the study period;Incidence of drug related adverse events Timepoint: Throughout the study period;Incidence of inpatient mortalityTimepoint: Throughout the study period | — |
Countries
India
Contacts
Public ContactMr Rahul Namjoshi
Apollo Hospitals
Outcome results
None listed